Saga Pure ASA
14.1.2021 18:01:54 CET | Globenewswire | Press release
Reference is made to the stock exchange notice from Saga Pure ASA (the "Company ") dated 12 January 2021 with further information regarding the three subsequent offerings currently being carried out (the "Subsequent Offerings "). The subscription period in the Subsequent Offerings commenced on 13 January 2021.
Following a recalculation of the number of subscription rights granted in the Subsequent Offerings, to ensure equal treatment of all shareholders that are eligible to participate in one or more of the Subsequent Offerings, the Company has determined to issue additional Subscription Rights.
As a consequence of this, the number of Subscription Rights required for subscribing and being allotted one (1) Offer Share in the Subsequent Offerings has increased. The new subscription ratio is 1.06 Subscription Rights per Offer Share, and this applies for all of the three Subsequent Offerings. Consequently, eligible shareholders who subscribe for Offer Shares will be granted one (1) Offer Share per 1.06 Subscription Right exercised in the relevant Subsequent Offering.
Shareholders who have questions about the Subsequent Offerings, the Subscription Rights and the Offer Shares may contact Fearnley Securities AS on the following telephone number:
Fearnley Securities: +47 22 93 60 00
For other questions, please contact:
Espen Lundaas, CFO, +47 92 43 14 17
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
